http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-60108068-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2001-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905195aa7e8b8f17c52c24148380dd41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16064742da5333efa70d5f5c99194372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4be5f485a0b6a5e599fb595c6d9cbcd4
publicationDate 2005-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-60108068-T2
titleOfInvention TREATMENT OF DIABETIC ULCERA
abstract This invention relates to the use of cyclic guanosine 3', 5'-monophosphate phosphodiesterase type five (cGMP PDE5) inhibitors, including in particular the compound sildenafil, for the treatment of diabetic ulcers, particularly diabetic foot ulcers.
priorityDate 2000-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466548927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467908233

Total number of triples: 22.